发明名称 OLIGOMERIC COMPOUNDS FOR THE MODULATION OF HIF-1A EXPRESSION
摘要 Oligonucleotides directed against the hypoxia-inducible factor-1alpha (HIF-1alpha) gene are provided for modulating the expression of HIF-1alpha. The compositions comprise oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding the HIF-1alpha. Methods of using these compounds for modulation of HIF-1alpha expression and for the treatment of diseases associated with the hypoxia-inducible factor-1alpha are provided. Examples of diseases are cancer and pre-eclampsia. The oligonucleotides may be composed of deoxyribonucleosides, a nucleic acid analogue, or Locked Nucleic Acid (LNA) or a combination thereof.
申请公布号 US2013116309(A1) 申请公布日期 2013.05.09
申请号 US201213725540 申请日期 2012.12.21
申请人 ENZON PHARMACEUTICALS, INC.;SANTARIS PHARMA A/S;SANTARIS PHARMA A/S;ENZON PHARMACEUTICALS, INC. 发明人 THRUE CHARLOTTE ALBAEK;HOG ANJA MOLHART;KRISTJANSEN PAUL E.G.
分类号 A61K31/7088;C12N15/09;A61K31/70;A61K38/00;A61K45/06;A61K48/00;A61P1/00;A61P3/00;A61P25/28;A61P29/00;A61P35/00;A61P43/00;C07H21/00;C07H21/04;C12N15/113 主分类号 A61K31/7088
代理机构 代理人
主权项
地址